Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas W Wastesson

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Public Health|March 14, 2024
Long-term care use, hospitalizations and mortality during COVID-19 in Finland and Sweden: A nationwide register-based study in 2020Pierre-Olivier Blotière, Géric Maura, Jani Raitanen, et al.
Journal of the American Geriatrics Society|October 31, 2023
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled studyMáté Szilcz, Jonas W Wastesson, Amaia Calderón-Larrañaga, et al.
Aging|May 24, 2020
Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult miceFrancesca Eroli, Kristina Johnell, María Latorre Leal, et al.
Annals of Internal Medicine|June 30, 2025
Medications and Risk for Microscopic Colitis: A Nationwide Study of Older Adults in SwedenHamed Khalili, Emma E McGee, Prasanna K Challa, et al.
Annals of Epidemiology|July 11, 2024
Comparison of sociodemographic factors, healthcare utilisation by general practitioner visits, somatic hospital admissions, and medication use in Norway, Sweden, and DenmarkMette Bliddal, Emma Bjørk, Øystein Karlstad, et al.
European Geriatric Medicine|May 16, 2024
Applicability of STOPP/START prescribing criteria in integrated Swedish administrative health registries and a Swedish population-based cohortCheima Amrouch, Souad Amrouch, Lu Dai, et al.
Basic & Clinical Pharmacology & Toxicology|October 31, 2022
Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020Mikkel Højlund, Larus S Gudmundsson, Jacob H Andersen, et al.
Eclinicalmedicine|October 21, 2024
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial studyBowen Tang, Arvid Sjölander, Jonas W Wastesson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Commonly prescribed multi-medication therapies exert sex-specific effects on Alzheimer's disease pathology and metabolomic profiles in App<sup>NL-G-F</sup> mice: Implications for personalized therapeutics in agingFrancesca Eroli, Kristina Johnell, Zeynep Acararicin, et al.
Journal of the American Medical Directors Association|January 24, 2018
Research Priorities for Optimizing Geriatric Pharmacotherapy: An International ConsensusEdwin C K Tan, Janet K Sluggett, Kristina Johnell, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Public Health|March 14, 2024
Long-term care use, hospitalizations and mortality during COVID-19 in Finland and Sweden: A nationwide register-based study in 2020Pierre-Olivier Blotière, Géric Maura, Jani Raitanen, et al.
Journal of the American Geriatrics Society|October 31, 2023
Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs and the risk of peptic ulcers: A self-controlled studyMáté Szilcz, Jonas W Wastesson, Amaia Calderón-Larrañaga, et al.
Aging|May 24, 2020
Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult miceFrancesca Eroli, Kristina Johnell, María Latorre Leal, et al.
Annals of Internal Medicine|June 30, 2025
Medications and Risk for Microscopic Colitis: A Nationwide Study of Older Adults in SwedenHamed Khalili, Emma E McGee, Prasanna K Challa, et al.
Annals of Epidemiology|July 11, 2024
Comparison of sociodemographic factors, healthcare utilisation by general practitioner visits, somatic hospital admissions, and medication use in Norway, Sweden, and DenmarkMette Bliddal, Emma Bjørk, Øystein Karlstad, et al.
European Geriatric Medicine|May 16, 2024
Applicability of STOPP/START prescribing criteria in integrated Swedish administrative health registries and a Swedish population-based cohortCheima Amrouch, Souad Amrouch, Lu Dai, et al.
Basic & Clinical Pharmacology & Toxicology|October 31, 2022
Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020Mikkel Højlund, Larus S Gudmundsson, Jacob H Andersen, et al.
Eclinicalmedicine|October 21, 2024
Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial studyBowen Tang, Arvid Sjölander, Jonas W Wastesson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Commonly prescribed multi-medication therapies exert sex-specific effects on Alzheimer's disease pathology and metabolomic profiles in App<sup>NL-G-F</sup> mice: Implications for personalized therapeutics in agingFrancesca Eroli, Kristina Johnell, Zeynep Acararicin, et al.
Journal of the American Medical Directors Association|January 24, 2018
Research Priorities for Optimizing Geriatric Pharmacotherapy: An International ConsensusEdwin C K Tan, Janet K Sluggett, Kristina Johnell, et al.
Pageof 6